Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MDV3100
MDV3100
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Thu, 05/31/12 - 10:17 am
Medivation
prostate cancer
MDV3100
Astellas
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
JNJ
prostate cancer
Dendreon
Provenge
Medivation
Zytiga
MDV3100
Medivation says prostate cancer pill MDV3100 met goal in second clinical trial
Yahoo/AP
Wed, 02/1/12 - 12:21 pm
Medivation
prostate cancer
MDV3100
Medivation Shrugs Off Alzheimer's Setback as Investors Eye New Prostate Cancer Data
TheStreet.com
Tue, 01/17/12 - 11:32 am
Medivation
prostate cancer
Alzheimer's disease
MDV3100
Medivation Back to Neutral
Yahoo/Zacks
Sat, 11/26/11 - 10:22 am
Medivation
MDV3100
prostate cancer
Medivation Up 140% In One Day, While Dendreon Gets Quartered
Seeking Alpha
Sat, 11/5/11 - 02:35 pm
Medivation
Dendreon
Provenge
MDV3100
prostate cancer
Medivation rockets 120% on drug study
Marketwatch
Thu, 11/3/11 - 12:21 pm
Medivation
prostate cancer
MDV3100
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer
Analysis: New drugs drive prostate cancer market
Yahoo/AP
Mon, 09/19/11 - 06:08 pm
prostate cancer
Dendreon
Exelixis
JNJ
MDV3100
Medivation
Provenge
cabozatinib
Zytiga
Medivation Remains Neutral
Yahoo/Zacks.com
Tue, 09/13/11 - 10:15 am
Medivation
JNJ
Pfizer
dimebon
Alzheimer's disease
prostate cancer
MDV3100
Medivation and Astellas Announce New Study Results Confirming Clinical Effects and Tolerability of MDV3100 in Advanced Prostate Cancer
Yahoo/MarketWire
Sat, 06/4/11 - 10:01 am
Medivation
Astellas
MDV3100
prostate cancer
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
Wed, 06/1/11 - 07:52 am
Amarin
AMR101
cabozantinib
Exelixis
HIV quad pill
Gilead Sciences
Medivation
MDV3100
Astellas
Vical
skin cancer
YM BioSciences
nimotuzumab
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Fierce Biotech
Thu, 05/19/11 - 02:08 pm
abiraterone
prostate cancer
Medivation
MDV3100
dimebon
Pfizer
Astellas
MDV3100 in New Phase II Study
Yahoo/Zacks
Sat, 05/14/11 - 12:52 pm
Medivation
MDV3100
prostate cancer
Casodex
AstraZeneca
Astellas
Medivation Reports First Quarter 2011 Financial Results and Provides Corporate Update
Yahoo/MarketWire
Sat, 05/7/11 - 10:07 am
Medivation
MDV3100
prostate cancer
earnings
Must Read: From Glivec To Medivation
Forbes
Wed, 05/4/11 - 12:35 pm
Glivec
Medivation
prostate cancer
MDV3100
Medivation Shares Popped: What You Need to Know
Motley Fool
Sat, 04/30/11 - 09:56 am
Medivation
MDV3100
prostate cancer
Alzheimer's disease
dimebon
Medivation Shares Popped: What You Need to Know
Motley Fool
Sat, 04/2/11 - 10:17 am
Medivation
MDV3100
prostate cancer
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
Mon, 03/21/11 - 02:56 pm
prostate cancer
Medivation
JNJ
Pfizer
Astellas
MDV3100
abiraterone
Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
Yahoo/PR NewsWire
Sat, 11/6/10 - 12:51 pm
Medivation
MDV3100
prostate cancer
PREVAIL trial